28 C
Mumbai
Saturday, July 11, 2020

India’s Covid-19 vaccine candidate Covaxin: All you need to know | India News – Times of India

Must read

Morphe Cosmetics Cuts Ties With Jeffree Star After Jackie Aina and More YouTubers Speak Out – E! Online

Morphe is envisioning their future without Jeffree Star.In a statement released on Friday, the makeup company stated they are working towards cutting ties with the...

Jada Pinkett Smith Admits to Past Relationship With August Alsina While Separated From Will Smith – E! Online

Jada Pinkett Smith promised to bring herself to the red table, and she did not disappoint. On Friday's episode of her Facebook Watch Show Red Table...

Liz Lemon Hasn’t Changed a Bit in Hilarious 30 Rock Reunion Special Teaser – E! Online

"How did you slap me?" Liz asks Jack Donaghy (Baldwin) during a phone call. "I have the iPhone 40," he responds.LOL!Watch the hilarious 30...

Armie Hammer and Elizabeth Chambers Break Up After 10 Years of Marriage – E! Online

Armie Hammer and Elizabeth Chambers are going their separate ways after 10 years of marriage.In a statement shared to their respective Instagram accounts, alongside a...


NEW DELHI: No vaccine has yet been approved for commercial use against Covid-19 but over a dozen vaccines from more than a 100 candidates globally are being tested in humans. India making its headway in the vaccine race earlier this week allowed one of the vaccine candidates to move to human clinical trials.
What is Covaxin
Covaxin is India’s first vaccine candidate to have gone into human clinical trials.
Bharat Biotech, the Hyderabad-based vaccine major, announced this week that its Covid-19 vaccine candidate has been approved by the Drug Controller General of India (DCGI) for phase I and II human clinical trials.
The SARS-CoV-2 strain was isolated in NIV, Pune and transferred to Bharat Biotech. The indigenous, inactivated vaccine developed and manufactured in Bharat Biotech’s BSL-3 (Bio-Safety Level 3) High Containment facility located in Genome Valley, Hyderabad, India.
The Drug Controller General of India – CDSCO, Ministry of Health & Family Welfare granted permission to initiate Phase I & II human clinical trials after the company submitted results generated from preclinical studies, demonstrating safety and immune response.
Human clinical trials are scheduled to start across India in July 2020.

India News | Latest News Headlines & Live Updates from India – Times of India

Source – timesofindia.indiatimes.com

Kevin M. Thompson
Kevin M. Thompson
Kevin M. Thompson is one of the best editor we have. He loves to write and curate a comprehensive article on any topic.
- Advertisement -India's Covid-19 vaccine candidate Covaxin: All you need to know | India News - Times of India

More articles

LEAVE A REPLY

Please enter your comment!
Please enter your name here

- Advertisement -India's Covid-19 vaccine candidate Covaxin: All you need to know | India News - Times of India

Latest article